Updated UCLA pre-op extremity #sarcoma 30 Gy in 5 fractions continue to show excellent outcomes: min 2 years, 6.5% LR, 13% late RT tox, 26.7% major WC. They're teasing 25 Gy in 5 fractions with chemotherapy too 😃 When is it standard? Shauna Campbell, DO Chirag Shah Mudit Chowdhary, MD

In anticipation of #ctos2021, a group picture of ⁦McGill_Sarcoma⁩: ⁦Sinziana Dumitra MD MSc(Epi) FRCSC⁩ , ⁦Fabio Cury⁩ , myself and a few Twitterless colleagues .

It was a pleasure to share the stage (or the screen) with old and new friends and talk about Sarcoma at the #semanaonco. Alessandro Gronchi - hoping to see you in person, in Brazil, soon.

Third dose received. Merci palais des congrès team for accommodating healthcare workers in the absence of a coordinated response in some hospitals.

Role of Serum Lymphocyte-derived Biomarkers in Nonmetastatic Muscle-invasive Bladder Cancer Patients Treated with Trimodal Therapy. sciencedirect.com/science/articl… Ronald Kool

Educação continuada em radioterapia. Aula hoje sobre câncer de bexiga com o Dr. Fabio Cury Fabio Cury

Happening now! DAY 1 | CANADIAN BLADDER CANCER FORUM 22 Thank you to our speakers #CBForum22 If you want to join us tomorrow, register here:cua.org/event/9245 Peter Black KSridhar Aly-Khan Lalani Madhuri Koti Rob Siemens Fabio Cury

“Meta-analysis of elective pelvic nodal irradiation using moderate hypofractionation for high-risk prostate cancer” (MENHYP-ENI) redjournal.org/article/S0360-… Andre G, MD, Rad Onc ⚽️ 🇮🇹 🇨🇦 Gustavo Fabio Cury

Meta-analysis of elective pelvic nodal irradiation Final version just released! Congrats: Gustavo Fabio Cury Dr. Fabio Moraes authors.elsevier.com/c/1fPAc1Hx52CG…

Trimodality bladder preservation versus cystectomy for muscle invasive bladder cancer; matched cohort #ASTRO22 OncoAlert. Dr J Efstathiou - outcomes similar for TMT versus cystectomy. 13% required salvage cystectomy, but did not impact survival. Hydronephrosis a bad player ☹️

Kidney cancer staging in one figure. #KidneyCancer AJCC 8th ed

We are hiring an assistant professor who will focus on #immunology and #bladdercancer McGill Dept of Surg Centre universitaire de santé McGill McGill University strong and supportive academic environment in the wonderful city of @montreal please apply or RT mcgill.wd3.myworkdayjobs.com/McGill_Careers…

Congrats Ronald Kool on a great talk showing benefits of whole pelvis radiation vs bladder only for #bladdercancer patients treated with #radiation …a rational approach to advocate treatment of pelvic lymph nodes to enhance cure, and similar to what is done with radical surgery

Canadian experience on 864 patients treated with #radiation based therapy for muscle invasive #bladdercancer. Results from real world experience among tertiary centres mirrors data from reported clinical trials. pubmed.ncbi.nlm.nih.gov/37005214/

Excited for an oral presentation on #IROCK at #ASTRO2023 in San Diego! Thank you for the support Rohann Correa Alex Louie MD, PhD Shankar Siva Muhammad Ali Alexander Muacevic Lee Ponsky Simon Lo Anand Swaminath Fabio Cury Michael Staehler Nicholas Zaorsky, MD MS ASTRO #astro23 #radonc

In press

Medical Oncology #fellowship program is open again!! #GUtumors , #Sarcoma, #ClinicalTrials and others. Apply if interested, fellowships are paid! applications are open 🥼 at @McgillOncology mcgill.ca/pgme/fellowshi…

🔥Hot off the press European Urology Oncology IROCK 🇨🇦🇦🇺🇺🇸🇩🇪🇯🇵 demonstrating #SABR ⚡️yields moderate long-term renal function decline, low dialysis rates even in patients with a solitary kidney #radonc authors.elsevier.com/c/1jOzs9Cfv--d… Thankful for mentors Shankar Siva Alex Louie MD, PhD Rohann Correa

🇨🇦🇨🇦 Goosebumps. #ResearchMatters #EndIt

🔬 10-year HYPO-RT-PC trial update: UHF 📆2.5 weeks 7# = CF 📆8 weeks 39# ✅ Same survival & toxicity ➡️ UHF may be more efficient! #ESTRO25 #ProstateCancer